No Significant Difference Between Initial CTO-PCI and No CTO-PCI Strategies in 10-Year Follow-Up
In the 10-year extended follow-up of the DECISION-CTO trial, an initial strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) was not associated with a significant difference in the primary composite endpoint of death, myocardial infarction, stroke, or any revascularization compared with a no CTO-PCI strategy (33.9% vs […]